Mathematical modeling of mutant transferrin-CRM107 molecular conjugates for cancer therapy

DOI10.1016/J.JTBI.2017.01.008zbMATH Open1368.92078OpenAlexW2567913608WikidataQ46420117 ScholiaQ46420117MaRDI QIDQ2013435FDOQ2013435

Authors: Dennis J. Yoon, Kevin Y. Chen, André M. Lopes, April A. Pan, Joseph Shiloach, Anne B. Mason, Daniel T. Kamei 

Publication date: 18 August 2017

Published in: Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc5310938

Recommendations

• Mathematical modeling and analysis of CD200-CD200R in cancer treatment
• Mathematical modeling and optimization of intratumor drug transport
• Development and Validation of a Mathematical Model to Describe Anti-Cancer Prodrug Activation by Antibody-Enzyme Conjugates
• Mathematical modeling of chemotherapy strategies in vascular tumor growth using nanopar\-ti\-cles
• Modeling the transfer of drug resistance in solid tumors
• scientific article; zbMATH DE number 1262330
• Mathematical model creation for cancer chemo-immunotherapy
• Mathematical modelling of cancer stem cell-targeted immunotherapy
• A NEW MATHEMATICAL MODELING AND SUB-OPTIMAL CHEMOTHERAPY OF CANCER
• Mathematical model of optimal chemotherapy and oncolytic virotherapy

zbMATH Keywords

drug deliverydiphtheria toxintargeted toxin

Mathematics Subject Classification ID

Medical applications (general) (92C50) Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45)

Cited In (2)

• Theoretical analysis of conjugate localization in two-step cancer chemotherapy
• The natural anticancer agent cucurbitacin inhibits specifically the stem cell factor binding to its receptor, c-kit

This page was built for publication: Mathematical modeling of mutant transferrin-CRM107 molecular conjugates for cancer therapy

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2013435)